Biomedical Engineering Reference
In-Depth Information
115. Allen, T. M.; Mumbengegwi, D. R.; Charrois, G. J. Anti-CD19-Targeted Liposomal Doxorubi-
cin Improves the Therapeutic Efficacy in Murine B-Cell Lymphoma and Ameliorates the Toxic-
ity of Liposomes with Varying Drug Release Rates.
Clin. Cancer. Res.
2005,
11,
3567-3573.
116. Chonn, A.; Semple, S. C.; Cullis, P. R. Association of Blood Proteins with Large Unilamellar
Liposomes in Vivo. Relation to Circulation Lifetimes.
J. Biol. Chem.
1992,
267,
18759-18765.
117. Dagar, S.; Sekosan, M.; Lee, B. S.; Rubinstein, I.; Onyuksel, H. VIP Receptors as Molecular
Targets of Breast Cancer: Implications for Targeted Imaging and Drug Delivery.
J. Controlled
Release
2001,
74,
129-134.
118. Drummond, D. C.; Meyer, O.; Hong, K.; Kirpotin, D. B.; Papahadjopoulos, D. Optimizing
Liposomes for Delivery of Chemotherapeutic Agents to Solid Tumors.
Pharmacol. Rev.
1999,
51,
691-743.
119. Fetterly, G. J.; Straubinger, R. M. Pharmacokinetics of Paclitaxel-Containing Liposomes in
Rats.
AAPS. PharmSci.
2003,
5,
1-11.
120. Heath, J. R.; Davis, M. E. Nanotechnology and Cancer.
Annu. Med. Rev.
2008,
59,
251-265.
121. Hoarau, D.; Delmas, P.; David, S.; Roux, E.; Leroux, J. C. Novel Long Circulating Lipid
Nanocapsules.
Pharm. Res.
2004,
21,
1783-1789.
122. Jin, S.; Ye, K. Nanoparticle-Mediated Drug Delivery and Gene Therapy.
Biotechnol. Prog.
2007,
23,
32-41.
123. Kamps, J. A.; Scherphof, G. L. Receptor Versus Non-Receptor Mediated Clearance of Lipo-
somes.
Adv. Drug. Deliv. Rev.
1998,
32,
81-97.
124. Mattiasson, B.; Borrebaeck, C. In
Enzyme Immunoassay
; Maggio, E. T., Ed.; CRC Press, Inc.:
Boca Raton, 1980; pp 295.
125. Moghimi, S. M.; Szebeni, J. Stealth Liposomes and Long Circulating Nanoparticles: Critical
Issues in Pharmacokinetics, Opsonization and Protein-Binding Properties.
Prog. Lipid. Res.
2003,
42,
463-478.
126. Morgen, M.; Lu, G. W.; Dub, D.; Stehle, R.; Lembke, F.; Cervantes, J., et al. Targeted Delivery
of a Poorly Water-Soluble Compound to Hair Follicles using Polymeric Nanoparticle Suspen-
sions.
Int. J. Pharm.
2011
, In Press.
127. Papahadjopoulos, D.; Jacobson, K.; Nir, S.; Isac, T. Phase Transitions in Phospholipid Ves-
icles. Fluorescence Polarization and Permeability Measurements Concerning the Effect of
Temperature and Cholesterol.
Biochim. Biophys. Acta.
1973,
311,
330-348.
128. Pastorino, F.; Brignole, C.; Marimpietri, D.; Sapra, P.; Moase, E. H.; Allen, T. M., et al. Doxo-
rubicin-Loaded Fab' Fragments of Anti-Disialoganglioside Immunoliposomes Selectively
Inhibit the Growth and Dissemination of Human Neuroblastoma in Nude Mice.
Cancer Res.
2003,
63,
86-92.
129. Tiwari, S. B.; Amiji, M. M. A Review of Nanocarrier-Based CNS Delivery Systems.
Curr.
Drug. Del.
2006,
3,
219-232.
130. Tobio, M.; Sanchez, A.; Vila, A.; Soriano, I.; Evora, C.; Vila-Jato, J. L., et al. Investigation
of Lectin-Modified Insulin Liposomes as Carriers for Oral Administration.
Colloids Surf B.:
Biointerfaces
2000,
18,
315-323.
131. Torchilin, V. P.; Shtilman, M. I.; Trubetskoy, V. S.; Whiteman, K.; Milstein, A. M. Amphiphilic
Vinyl Polymers Effectively Prolong Liposome Circulation Time in Vivo.
Biochim. Biophys.
Acta.
1994,
1195,
181-184.
132. Yan, X.; Kuipers, F.; Havekes, L. M.; Havinga, R.; Dontje, B.; Poelstra, K., et al. The Role of
Apolipoprotein E in the Elimination of Liposomes from Blood by Hepatocytes in the Mouse.
Biochem. Biophys. Res. Commun.
2005,
328,
57-62.
